Renal transplantation in light chain amyloidosis: coming out of the cupboard

Outcome in Renal AL Amyloidosis After Chemotherapy

(2011) Jennifer H. Pinney et al.   JOURNAL OF CLINICAL ONCOLOGY

Solid Organ Transplantation in AL Amyloidosis

(2010) P. T. Sattianayagam et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis

(2010) W. Lamm et al.   ANNALS OF HEMATOLOGY

Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study

(2010) P. Moreau et al.   BLOOD

Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis

(2010) Efstathios Kastritis et al.   JOURNAL OF CLINICAL ONCOLOGY

Activated human B cells: stimulatory or tolerogenic antigen-presenting cells?

(2009) A. Shimabukuro-Vornhagen et al.   BLOOD

Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study

(2009) D. E. Reece et al.   BLOOD

Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney

(2009) M. A. Gertz et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Heart transplantation in systemic (AL) amyloidosis: A retrospective study of eight French patients

(2008) Aude Mignot et al.   Archives of Cardiovascular Diseases

Presentation and Outcome of Patients with Systemic Amyloidosis Undergoing Dialysis

(2008) G. Bollee et al.   Clinical Journal of the American Society of Nephrology

Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease

(2008) A. D. Wechalekar et al.   HAEMATOLOGICA